PRELIMINARY PROGRAM
Hotel Kalastajatorppa, Helsinki

WEDNESDAY | 1.9.2021

  • 17.00 - 20.00: Nordic Board Meeting (Invitation only)

    20.00 - 22.00: Dinner for NBM and Round Table participants (Invitation only)

THURSDAY | 2.9.2021

  • Coffee and registration | 09.00 - 10.00

  • Sessio I
    Melanoma diagnosis (Chair: TBC)

    10.00 - 10.05: Welcome and opening remarks

    10.05 - 10.35: Molecular pathology in melanocytic tumours - Dr Arnaud de la Fouchardière, Lyon, France

    10.35 - 11.00: cDNA as a noninvasive tool for monitoring response in metastatic melanoma - Dr Teofila Caplanusi-Seremet, Brussels, Belgium

    11.00 - 11.30: Artificial intelligence for image based melanoma diagnostics - Nina Linder, Helsinki, Finland

    11.30 - 12.15: Abstracts (3 x 15 min)

  • Lunch | 12.15 - 13.15

  • Sessio II
    Translational medicine in melanoma (Chair: TBC)

    13.15 - 14.00: Importance of microenvironment of the tumor and host in systemic treatment of melanoma - Prof. John Haanen, Amsterdam, The Netherlands

    14.00 - 14.30: New tools to prevent cancer growth and spread: A clever approach - Maija Hollmén, Turku, Finland

    14.30 - 15.00: Abstracts (2 x 15 min)

  • Coffee break | 15.00 - 15.30

  • Sessio III
    Locally advanced melanoma (Chair, TBC)

    15.30 - 16.10: Treatment options for locally advanced melanoma including neoadjuvant treatment - Alexander van Akkooi, Netherlands

    16.10 - 16.40: Abstracts (2 x 15 min)

  • Sessio IV
    Acta Oncologica session: Metastatic melanoma, toxicity of new treatments, patient cases and panel (Chair: TBC)

    16.45 - 17.30: Toxicity management of immunotherapies - Prof John Haanen, Amsterdam, The Netherlands

    17.30 - 18.30: Patient cases (4 x 15 min) evaluated by a panel; the winning case will be published as a short report in Acta Oncologica
    Panel: Haanen, Nyakas, Skyttä, Hernberg

  • Dinner | 19.30 - 00.00

    Award of best patient case
    STAND UP: André Wickström
    (25 - 30 min)

FRIDAY | 3.9.2021

  • Sessio V
    Local melanoma (Chair, TBC)

    8.30 - 9.15: Early diagnostics of melanoma - Associate Prof. John Paoli, Gothenburg, Sweden

    9.15 - 10.00: CLND for whom after Sentinel Node Biopsy - Dr Alexander van Akkooi, Netherlands

    • Coffee Break | 10.00 - 10.30

  • Sessio VI
    Challenges in the treatment of advanced melanoma (Chair: TBC)

    10.30 - 11.15: Systemic treatment options for recurrence after adjuvant or 1st line treatment for BRAF wt melanoma patients - Prof. Jeff Weber, NY, USA

    11.15 - 12.00: Modern immunotherapy for melanoma patients with autoimmune disease - Dr Marta Nyakas, Oslo, Norway

    12.00 - 13.00: Abstracts (4 x 15 min)

  • Lunch | 13.00 - 14.00

  • Sessio VII
    Treatment of patients with brain metastases (Chair: TBC)

    14.00 - 14.40: Systemic treatment for patients with brain metastases - Prof. Jeff Weber, NY, USA

    14.40 - 15.20: Radiotherapy of brain metastases - Dr Tanja Skyttä, Tampere, Finland

    15.20 - 16.00: Radiotherapy combined with immunotherapy - Dr Teofila Caplanusi-Seremet, Brussels, Belgium

  • Closing remarks | 16.00

  • Departures | 16.15

Program steering committee:

Micaela Hernberg, Suvi Ilmonen, Hanna Karhapää, Tiia Kettunen, Laura Kohtamäki, Jussi Koivunen, Kristiina Korhonen-Tyynelä, Kalle Mattila, Siru Mäkelä, Johanna Palve, Tanja Skyttä, Leena Tiainen, Sanni Tulokas, Pia Vihinen, Meri-Sisko Vuoristo

Conference assistants: Elisa Koskelainen & Jutta Korpela

GOLDEN SPONSORS

Bristol-Myers Squibb MSD Novartis Sanofi

SILVER SPONSORS

Merck-Pfizer Pierre Fabre

BRONZE SPONSORS

Merck-Pfizer